Proceedings of 40th Annual General Meeting for the Financial Year 2024-25.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Brawn Biotech Ltd held its 40th Annual General Meeting on September 30, 2025, at 11:00 AM via Video Conferencing, with 51 members attending. Chairman Mr. Brij Raj Gupta chaired the meeting, and the audited financial statements for FY ending March 31, 2025 were adopted. Four resolutions were voted on, including the reappointment of Mrs. Brij Bala Gupta (Director, retiring by rotation), reappointment of Mr. Amit Kumar as Manager (KMP), and a special resolution to adopt the Memorandum of Association as per the Companies Act, 2013. All four resolutions were passed with the requisite majority, and there were no qualifications in the Audit Report or Secretarial Audit Report. Four shareholders registered as speakers and raised a few questions, which were addressed by the Company Secretary.
The smooth passage of all resolutions, including board continuity and MOA alignment with current law, signals routine corporate governance with no shareholder dissent. No material financial or strategic surprises were announced, so this filing is largely procedural with neutral near-term impact on the stock.